The CONMED Corporation is a publicly traded American manufacturer of medical equipment, primarily orthopedic, endoscopy, and generalsurgical tools.[2] In 2021, orthopedics made up $550 million of its revenue.[3] It is part of the S&P 600. It has manufacturing facilities in the United States and Mexico, and sales and distribution offices internationally.[1][4]
In 1970, Eugene Corasanti (1930–2015) purchased a small medical supplied distributor in Utica, New York. He originally named the company Concor Enterprises, but later renamed it to Consolidated Medical Equipment, Inc.[8] Its first product was a disposable ECG electrode.[2] Corasanti served as CEO until 2006 and chairman of the board until 2014. By the time he retired, CONMED had grown to around $700 million of sales.[8]
In May 2003 CONMED was cited by the FDA for violations at its Colorado plant.[9] Later in 2003, it filed suit against Johnson & Johnson, alleging that Johnson & Johnson was illegally coercing hospitals into purchasing their surgical instruments.[10] A financial analyst for Zacks in 2006 criticized CONMED for taking on the financial strain of this suit, combined with poor growth and debt from recent acquisitions.[11]
Eugene's son Joseph J. Corasanti replaced him as CEO in late 2006,[12] which was criticized by some as nepotism. At the time, the board had consisted entirely of Utica-area residents.[13] Joseph stepped down in 2014.[14]
In July 2022, CONMED moved its headquarters from Utica to Largo, Florida. Its plant in Utica remains open.[15]
^Armstrong, David (June 5, 2006). "Under the Knife". Forbes. Vol. 177, no. 12. EBSCOhost21396346.
^"Noted..."WSJ. November 3, 2006. Retrieved May 12, 2023.
^"Voce Capital Demands Changes at CONMED Corporation". Business Wire. November 4, 2013. EBSCOhostbizwire.c51624434.
^Reinhardt, Eric (August 1, 2014). "ConMed moves forward with interim CEO after Corasanti steps down". Business Journal (Central New York). Vol. 28, no. 30. pp. 2–9B. ISSN0894-5675. EBSCOhost97514948.